» Articles » PMID: 31166988

Anxiety-like Features and Spatial Memory Problems As a Consequence of Hippocampal SV2A Expression

Overview
Journal PLoS One
Date 2019 Jun 6
PMID 31166988
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The Synaptic Vesicle Protein 2A (SV2A) is a transmembrane protein whose presence is reduced both in animal models and in patients with chronic epilepsy. Besides its implication in the epileptic process, the behavioural consequences of the changes in its expression remain unclear. The purpose of our research is to better understand the possible role(s) of this protein through the phenotype of cKO (Grik4 Cre+/-, SV2A lox/lox) mice, male and female, which present a specific decrease of SV2A expression levels in the hippocampal glutamatergic neurons but without any epileptic seizures. In this study, we compare the cKO mice with cHZ (Grik4 Cre+/-, SV2A lox/+) and WT (Grik4 Cre+/+, SV2A lox/lox) mice through a battery of tests, used to evaluate different features: the anxiety-related features (Elevated Plus Maze), the locomotor activity (Activity Chambers), the contextual fear-related memory (Contextual Fear Conditioning), and the spatial memory (Barnes Maze). Our results showed statistically significant differences in the habituation to a new environment, an increase in the anxiety levels and spatial memory deficit in the cHZ and cKO groups, compared to the WT group. No statistically significant differences due to the genotype appeared in the spontaneous locomotor activity or the fear-linked memory. However, sexual differences were observed in this last feature. These results highlight not only an important role of the SV2A protein in the cognitive and anxiety problems typically encountered in epileptic patients, but also a possible role in the symptomatology of other neurodegenerative diseases, such as the Alzheimer's disease.

Citing Articles

Synaptic Vesicle Glycoprotein 2A Knockout in Parvalbumin and Somatostatin Interneurons Drives Seizures in the Postnatal Mouse Brain.

Bartholome O, Neirinckx V, De La Brassinne O, Desloovere J, Van Den Ackerveken P, Raedt R J Neurosci. 2025; 45(8).

PMID: 39753304 PMC: 11841765. DOI: 10.1523/JNEUROSCI.1169-24.2024.


Synaptic vesicle protein 2A mitigates parthanatos via apoptosis-inducing factor in a rat model of pharmacoresistant epilepsy.

Li C, Wang Z, Ren M, Ren S, Wu G, Wang L CNS Neurosci Ther. 2024; 30(5):e14778.

PMID: 38801174 PMC: 11129553. DOI: 10.1111/cns.14778.


The impact of brivaracetam on cognitive processes and anxiety in various experimental models.

Zwierzynska E, Pietrzak B Pharmacol Rep. 2024; 76(1):86-97.

PMID: 38182968 PMC: 10830775. DOI: 10.1007/s43440-023-00564-3.


Effects and Mechanisms of Synaptotagmin-7 in the Hippocampus on Cognitive Impairment in Aging Mice.

Xie Y, Zhi K, Meng X Mol Neurobiol. 2021; 58(11):5756-5771.

PMID: 34403042 DOI: 10.1007/s12035-021-02528-1.


Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218.

Jurkiewicz M, Moser D, Koller A, Yu L, Chen E, Bennett D Transl Psychiatry. 2020; 10(1):297.

PMID: 32839459 PMC: 7445165. DOI: 10.1038/s41398-020-00966-4.


References
1.
Magalhaes J, Gongora M, Vicente R, Bittencourt J, Tanaka G, Velasques B . The influence of levetiracetam in cognitive performance in healthy individuals: neuropsychological, behavioral and electrophysiological approach. Clin Psychopharmacol Neurosci. 2015; 13(1):83-93. PMC: 4423160. DOI: 10.9758/cpn.2015.13.1.83. View

2.
Keiser A, Turnbull L, Darian M, Feldman D, Song I, Tronson N . Sex Differences in Context Fear Generalization and Recruitment of Hippocampus and Amygdala during Retrieval. Neuropsychopharmacology. 2016; 42(2):397-407. PMC: 5399239. DOI: 10.1038/npp.2016.174. View

3.
Roelofs K . Freeze for action: neurobiological mechanisms in animal and human freezing. Philos Trans R Soc Lond B Biol Sci. 2017; 372(1718). PMC: 5332864. DOI: 10.1098/rstb.2016.0206. View

4.
Helmstaedter C, Witt J . Epilepsy and cognition - A bidirectional relationship?. Seizure. 2017; 49:83-89. DOI: 10.1016/j.seizure.2017.02.017. View

5.
Wiglusz M, Landowski J, Cubala W . Prevalence of anxiety disorders in epilepsy. Epilepsy Behav. 2017; 79:1-3. DOI: 10.1016/j.yebeh.2017.11.025. View